Quick Answer
Anbio Biotechnology reported Operating Income of $2.00 million for fiscal year 2024.
Anbio Biotechnology Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | $2.00M | +1.8% |
| 2023 | $1.96M | -80.8% |
| 2022 | $10.20M | — |
- Anbio Biotechnology showed an increase of +1.8% in Operating Income compared to the prior fiscal year.
- Over the 2022–2024 period, Anbio Biotechnology’s operating income has declined by 80.4% (from $10.20 million to $2.00 million).
- The most recent figure is from Anbio Biotechnology’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: